Comparing Ketamine and Fentanyl in Pediatric Tonsillectomy: Pain Control and Emergence Delirium Outcomes (KVFPT)
Key facts
- Who runs it
- Medipol University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 59 people enrolled
- Started
- 1 Jan 2023
- Ended
- 15 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- ketamine
- fentanyl
- Record updated
- 30 October 2024
Who can take part
- Age
- 3 years to 8 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Children aged 3 to 8 years
- Scheduled for tonsillectomy and adenoidectomy
- American Society of Anesthesiologists (ASA) Physical Status I-III
Who cannot take part
- Receiving chronic opioid analgesic therapy prior to surgery
- Known hypersensitivity or allergy to any of the study medications (acetaminophen, ketamine, fentanyl)
- Renal disease
- Hepatic disease
- Obesity (body mass index greater than 99th percentile for age)
- American Society of Anesthesiologists' Physical Status ≥4
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is designed to compare the effectiveness of two medications, ketamine and fentanyl, in managing pain and preventing delirium in children aged 3 to 8 years who are undergoing tonsillectomy and adenoidectomy surgery. The study aims to determine which medication is better at reducing pain and preventing delirium after surgery, and which one results in faster recovery times and fewer side effects. Children participating in the study will be randomly assigned to receive either ketamine or fentanyl during their surgery. The study will measure pain levels, recovery times, and any side effects experienced by the children. The results of this study will help doctors and anesthesiologists make better decisions about which medication to use for pain management in children undergoing tonsillectomy and adenoidectomy.
The 2 groups in the trial
- Group I (Ketamine group)Existing treatment, for comparison
The patients in this group will have intravenous ketamine (0.5 mg/kg) during induction
Treatment: ketamine
- Group II (Fentanyl Group)Treatment being tested
The patients in this group will have intravenous fentanyl (1 µg/kg) during induction
Treatment: fentanyl
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Clinical Trial Comparing Ketamine and Fentanyl for Postoperative Pain Management and Emergence Delirium Following Pediatric Tonsillectomy and Adenoidectomy
- Record updated
- 30 October 2024